NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE178919 Query DataSets for GSE178919
Status Public on Nov 29, 2022
Title Repurposing Tamoxifen as Potential Host-Directed Therapeutic For Tuberculosis
Organism Danio rerio
Experiment type Expression profiling by high throughput sequencing
Summary The global burden of tuberculosis (TB) is aggravated by the continuously increasing emergence of drug resistance, highlighting the need for innovative therapeutic options. The concept of host-directed therapy (HDT) as adjunctive to classical antibacterial therapy with antibiotics represents a novel and promising approach for treating TB. Here, we have focused on repurposing the clinically used anticancer drug tamoxifen, which was identified as a molecule with strong host-directed activity against intracellular Mycobacterium tuberculosis (Mtb). Using a primary human macrophage Mtb infection model, we demonstrate the potential of tamoxifen against drug-sensitive as well as drug-resistant Mtb bacteria. The therapeutic effect of tamoxifen was confirmed in an in vivo TB model based on Mycobacterium marinum infection of zebrafish larvae. Tamoxifen had no direct antimicrobial effects at the concentrations used, confirming that tamoxifen acted as an HDT drug. Furthermore, we demonstrate that the antimycobacterial effect of tamoxifen is independent of its well-known target the estrogen receptor (ER) pathway, but instead acts by modulating autophagy, in particular the lysosomal pathway. Through RNA sequencing and microscopic colocalization studies, we show that tamoxifen stimulates lysosomal activation and increases the localization of mycobacteria in lysosomes both in vitro and in vivo, while inhibition of lysosomal activity during tamoxifen treatment partly restores mycobacterial survival. Thus, our work highlights the HDT potential of tamoxifen and proposes it as a repurposed molecule for the treatment of TB.
 
Overall design Zebrafish embryos and their were manually dechorionated at 24 hours post fertilisation (hpf) and at 30 hpf they were infected by injecting 200 colony forming units of M. marinum strain M into the blood island. After injections embryos were transferred into fresh egg water containing Tamoxifen (10uM), Amiodarone (10uM), or DMSO (equal v/v as treatments) incubated for 2 days at 28,5°C. After the incubation period, infected and uninfected embryos and their controls (10 per sample) were snap-frozen in liquid nitrogen and RNA was isolated for Illumina RNAseq analysis.
 
Contributor(s) Boland R, Heemskerk MT, Forn-Cuní G, Korbee CJ, Walburg KV, Esselink JJ, Carvalho dos Santos C, de Waal AM, van der Hoeven DC, van der Sar E, Spaink HP, van der Vaart M, Haks MC, Meijer AH, Ottenhoff TH, de Ries AS, Xie J
Citation(s) 36475748
Submission date Jun 25, 2021
Last update date Jun 14, 2023
Contact name Ralf Boland
E-mail(s) ralf.boland@gmail.com
Organization name Leiden University
Department IBL-ASH-CO
Street address Einsteinweg 55
City Leiden
ZIP/Postal code 2313JA
Country Netherlands
 
Platforms (1)
GPL18413 Illumina HiSeq 2500 (Danio rerio)
Samples (24)
GSM5400906 1_DMSO_Mm_1
GSM5400907 2_TAM_Mm_1
GSM5400908 3_AMIO_Mm_1
Relations
BioProject PRJNA741500
SRA SRP325635

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE178919_RAW.tar 20.7 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap